42890-06-2

Basic information

• Product Name: (2R,3R,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carboxylic acid
• Synonyms: (2R,3R,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carboxylic acid
• CAS NO: 42890-06-2
• Molecular Weight: 448.516
• Mol File: 42890-06-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (2R,3R,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3R,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carboxylic acid(42890-06-2)
• EPA Substance Registry System: (2R,3R,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carboxylic acid(42890-06-2)

Safety Data

• Hazardous Substances Data: 42890-06-2(Hazardous Substances Data)

Upstream product

• 52492-43-0 2,5-anhydro-3,4,6-tri-O-benzyl-D-allononitrile 
• 58381-23-0 (3R,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-yl acetate 
• 16838-89-4 2,3,5-tri-O-benzyl-D-ribofuranose 
• 64363-77-5 methyl 2,3,5-tri-O-benzyl-D-ribofuranoside 
• 1824-96-0 methyl ribofuranoside 
• 532-20-7 D-Ribose 
• 82267-01-4 (2S,3S,4R,5R)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carbonitrile 

Downstream Products

• 136409-47-7 (3R,4R,5R)-3,4-Bis-benzyloxy-5-benzyloxymethyl-tetrahydro-furan-2-carboxylic acid 2-thioxo-2H-pyridin-1-yl ester 
• 136409-54-6 methyl 2-(2',3',5'-tri-O-benzyl-α-D-ribofuranosyl)isonicotinate 
• 136409-55-7 methyl 2-(2',3',5'-tri-O-benzyl-β-D-ribofuranosyl)isonicotinate 
• 113889-66-0 1-(2',3',5'-tri-O-benzyl-β-D-ribofuranosyl)-2-phenylacetylene 

Relevant articles and documents

ANTIVIRAL NUCLEOSIDES AND DERIVATIVES THEREOF

Disclosed herein are nucleoside compounds and derivatives thereof, pharmaceutical compositions containing same, and their methods of synthesis. The compounds are useful in treating orthomyxovirus infections, such as influenza infections.

4-AMINO-3-(2,3,5-TRI-O-BENZYL-β-D-RIBOFURANOSYL)-5-PYRAZOLECARBONITRILE. SYNTHESIS AND CONVERSION INTO A SUGAR-BLOCKED 5,7-DISUBSTITUTED FORMYCIN ANALOG

The title compound, a potential intermediate to protected C-nucleoside analogs related to formycin A, was synthesized via a new route wherein 2,3,5-tri-O-benzyl-1-O-(p-nitrophenyl)-D-ribofuranose was converted to 2,5-anhydro-3,4,6-tri-O-benzyl-D-allonic a